These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22655248)

  • 1. Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy.
    Lei S; Piel N; Oermann EK; Chen V; Ju AW; Dahal KN; Hanscom HN; Kim JS; Yu X; Zhang G; Collins BT; Jha R; Dritschilo A; Suy S; Collins SP
    Front Oncol; 2011; 1():48. PubMed ID: 22655248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing errors in prostate tracking with an improved fiducial implantation protocol for CyberKnife based stereotactic body radiotherapy (SBRT).
    Holmes OE; Gratton J; Szanto J; Vandervoort E; Doody J; Henderson E; Morgan SC; O'Sullivan J; Malone S
    J Radiosurg SBRT; 2018; 5(3):217-227. PubMed ID: 29988326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4D ultrasound speckle tracking of intra-fraction prostate motion: a phantom-based comparison with x-ray fiducial tracking using CyberKnife.
    O'Shea TP; Garcia LJ; Rosser KE; Harris EJ; Evans PM; Bamber JC
    Phys Med Biol; 2014 Apr; 59(7):1701-20. PubMed ID: 24619097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence-based framework in evaluating intrafraction motion for liver cancer robotic stereotactic body radiation therapy with fiducial tracking.
    Liang Z; Zhou Q; Yang J; Zhang L; Liu D; Tu B; Zhang S
    Med Phys; 2020 Nov; 47(11):5482-5489. PubMed ID: 32996131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective assessment of a single fiducial marker tracking regimen with robotic stereotactic body radiation therapy for liver tumours.
    Nakayama M; Uehara K; Nishimura H; Tamura S; Munetomo Y; Tsudou S; Mayahara H; Mukumoto N; Geso M; Sasaki R
    Rep Pract Oncol Radiother; 2019; 24(4):383-391. PubMed ID: 31297039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
    Oermann EK; Slack RS; Hanscom HN; Lei S; Suy S; Park HU; Kim JS; Sherer BA; Collins BT; Satinsky AN; Harter KW; Batipps GP; Constantinople NL; Dejter SW; Maxted WC; Regan JB; Pahira JJ; McGeagh KG; Jha RC; Dawson NA; Dritschilo A; Lynch JH; Collins SP
    Technol Cancer Res Treat; 2010 Oct; 9(5):453-62. PubMed ID: 20815416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Motion-dependent Clinical Outcome of Tumor Tracking Stereotactic Body Radiotherapy for Prostate Cancer.
    Choi HS; Kang KM; Jeong BK; Song JH; Lee YH; Ha IB; Kam SC; Hwa JS; Hyun JS; Do J; Jeong DH; Jeong H
    J Korean Med Sci; 2018 Apr; 33(14):e107. PubMed ID: 29607633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating intrafraction tumor motion during fiducial-based liver stereotactic radiotherapy via an iterative closest point (ICP) algorithm.
    Li WZ; Liang ZW; Cao Y; Cao TT; Quan H; Yang ZY; Li Q; Dai ZT
    Radiat Oncol; 2019 Oct; 14(1):185. PubMed ID: 31665054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy.
    Xu Q; Hanna G; Grimm J; Kubicek G; Pahlajani N; Asbell S; Fan J; Chen Y; LaCouture T
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):94-101. PubMed ID: 25195990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer.
    Levin-Epstein R; Qiao-Guan G; Juarez JE; Shen Z; Steinberg ML; Ruan D; Valle L; Nickols NG; Kupelian PA; King CR; Cao M; Kishan AU
    Front Oncol; 2020; 10():539. PubMed ID: 32373529
    [No Abstract]   [Full Text] [Related]  

  • 11. The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction Monitoring (KIM).
    Nguyen DT; O'Brien R; Kim JH; Huang CY; Wilton L; Greer P; Legge K; Booth JT; Poulsen PR; Martin J; Keall PJ
    Radiother Oncol; 2017 Apr; 123(1):37-42. PubMed ID: 28342648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer.
    Sanders MK; Moser AJ; Khalid A; Fasanella KE; Zeh HJ; Burton S; McGrath K
    Gastrointest Endosc; 2010 Jun; 71(7):1178-84. PubMed ID: 20362284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-dimensional computed tomography prediction of inter- and intrafractional upper gastrointestinal tumor motion during fractionated stereotactic body radiation therapy.
    Lischalk JW; Kole TP; Anjum HM; Obayomi-Davies O; Rashid A; Unger K
    Pract Radiat Oncol; 2016; 6(3):176-182. PubMed ID: 26746816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraprostatic fiducials in stereotactic radiotherapy for prostate cancer].
    Cordoba A; Pasquier D; Nickers P; Lacornerie T; Lartigau É
    Cancer Radiother; 2016 Dec; 20(8):815-819. PubMed ID: 27793529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.
    Mercado C; Kress MA; Cyr RA; Chen LN; Yung TM; Bullock EG; Lei S; Collins BT; Satinsky AN; Harter KW; Suy S; Dritschilo A; Lynch JH; Collins SP
    Front Oncol; 2016; 6():114. PubMed ID: 27200300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility.
    King CR; Lehmann J; Adler JR; Hai J
    Technol Cancer Res Treat; 2003 Feb; 2(1):25-30. PubMed ID: 12625751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying 6D tumor motion and calculating PTV margins during liver stereotactic radiotherapy with fiducial tracking.
    Sun X; Dai Z; Xu M; Guo X; Su H; Li Y
    Front Oncol; 2022; 12():1021119. PubMed ID: 36465406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation.
    Taillez A; Bimbai AM; Lacornerie T; Le Deley MC; Lartigau EF; Pasquier D
    Front Oncol; 2021; 11():690422. PubMed ID: 34336678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer.
    Oermann EK; Suy S; Hanscom HN; Kim JS; Lei S; Yu X; Zhang G; Ennis B; Rohan JP; Piel N; Sherer BA; Borum D; Chen VJ; Batipps GP; Constantinople NL; Dejter SW; Bandi G; Pahira J; McGeagh KG; Adams-Campbell L; Jha R; Dawson NA; Collins BT; Dritschilo A; Lynch JH; Collins SP
    J Hematol Oncol; 2011 Mar; 4():12. PubMed ID: 21439088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the intra- and interfractional tumor motion and variability by fiducial-based real-time tracking in liver stereotactic body radiation therapy.
    Liang Z; Liu H; Xue J; Hu B; Zhu B; Li Q; Zhang S; Wu G
    J Appl Clin Med Phys; 2018 May; 19(3):94-100. PubMed ID: 29493095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.